跳至主要内容
临床试验/NCT07388004
NCT07388004招募中不适用

Rewiring Expectations and Amplifying Rewards: A Study Protocol for a Randomized Controlled Trial of Mechanism-Based Group Psychotherapy for Major Depressive Disorder

Philipps University Marburg1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2025年10月13日最近更新:
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
150
试验地点
1
主要终点
Change in Depressive Symptoms (Beck Depression Inventory-II)

研究概览

简要总结

Major depressive disorder (MDD) is one of the most common psychiatric conditions and often remains difficult to treat effectively. Many patients continue to experience residual symptoms or relapse even after receiving established forms of psychotherapy. This study tests whether targeting specific psychological mechanisms can improve outcomes for people with depression. We compare two novel group therapies: (1) Expectation-Focused Psychotherapeutic Intervention (EFPI), which aims to modify rigid, negative expectations that maintain depressive symptoms, and (2) Reward Enhancement and Activation Therapy (REACT), which focuses on increasing sensitivity to positive experiences and strengthening reward-related learning. Both are delivered in a group format to foster peer support and shared learning.

A total of 150 adults with a current MDD diagnosis will be randomly assigned to EFPI, REACT, or a waiting-list control. Participants in the intervention groups receive 10 group sessions over five weeks. Waiting-list participants complete baseline and 3-month follow-up assessments before being offered standard treatment options.

Clinical outcomes are assessed at baseline, immediately after treatment, and at 3- and 6-month follow-ups (for the intervention groups). Primary outcomes are reductions in depressive symptoms measured by clinician ratings and self-report questionnaires. Secondary outcomes include changes in expectation processes and reward sensitivity.

In addition, functional MRI (fMRI) tasks examine brain mechanisms related to expectation updating and reward processing pre- and post-intervention, to help identify neural changes that may underlie symptom improvement.

By directly addressing dysfunctional expectations and reduced reward sensitivity, this study seeks to provide evidence for more targeted psychotherapeutic approaches. If successful, the results may support more personalized treatments and better long-term outcomes in MDD.

详细描述

Major depressive disorder (MDD) remains a leading cause of disability and often shows incomplete response or relapse after established treatments. A promising strategy is to move beyond broad, symptom-focused interventions toward therapies that directly target the psychological and neurobiological mechanisms maintaining depression. This trial evaluates two mechanism-based, group-delivered psychotherapies that each target a core process implicated in MDD: maladaptive expectation processing and reduced reward sensitivity.

Rationale and mechanistic framework. Expectation pathway. Predictive coding accounts propose that the brain continuously updates prior beliefs in light of new information. In depression, negative expectations about the self, others, and the future often become rigid and resistant to change. Cognitive immunization-discounting or reframing disconfirming evidence-prevents adaptive belief updating, maintains symptoms, and can weaken responses to conventional cognitive-behavioral interventions. Targeting dysfunctional expectations directly-via structured behavioral experiments that produce positive expectation violations and procedures that reduce cognitive immunization-may restore flexibility in belief revision and enhance treatment effects.

Reward pathway. Depressed patients frequently show reduced reward sensitivity, including blunted anticipation of reward and impaired reinforcement learning, processes linked to mesolimbic dopaminergic circuitry (e.g., ventral striatum/nucleus accumbens). These deficits can limit the benefit of nonspecific activity scheduling, which increases exposure to potentially rewarding situations but does not specifically remediate anticipatory and learning-related components of reward processing. Interventions that systematically enhance reward sensitivity and strengthen reinforcement contingencies may therefore improve motivational drive and positive affect.

Neurobiological component. Expectation updating has been associated with activity in the dorsolateral prefrontal cortex (DLPFC) and anterior insula, whereas reward processing consistently engages the ventral striatum and insular cortex. This trial includes a functional MRI (fMRI) module to probe these mechanisms pre- and post-intervention. Participants perform established paradigms tapping threat/expectation learning, future-directed thinking, and social reward/expectation. Linking neural responses to clinical change will clarify how mechanism-based therapies exert their effects and may inform biomarkers for treatment selection and monitoring.

Study design overview. This is a randomized, controlled, superiority trial with three parallel groups: (1) EFPI, (2) REACT, and (3) waiting-list control. The trial follows a 3 × 5 repeated-measures design with planned assessments at baseline (pre-treatment), post-treatment (after 5 weeks), and 3- and 6-month follow-ups. Intervention groups complete all follow-ups; after the 6-month assessment they may initiate further treatment if desired. Waiting-list participants complete baseline and the 3-month follow-up before being ethically permitted to access other treatments. They continue to receive follow-up questionnaires at later time points, including items on additional treatments, to enable sensitivity analyses.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

盲法说明

Independent outcome assessors conducting clinician-rated measures (e.g., HAMD-21) will remain blinded to group allocation. Participants, therapists, and investigators are not blinded.

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age: 18-80 years
  • Current diagnosis of major depressive disorder (MDD) according to DSM-5, confirmed by structured clinical interview (e.g., DIPS)
  • Hamilton Depression Rating Scale (HAMD-21) score ≥ 9
  • Ability to attend group therapy sessions (2×/week for 5 weeks)
  • Ability to undergo MRI scanning (for participants in the fMRI component) Written informed consent

排除标准

  • Current or lifetime diagnosis of bipolar disorder, psychotic disorder, or primary substance use disorder
  • High acute suicide risk requiring immediate intervention
  • Severe neurological disorder, brain injury, or contraindications for MRI (e.g., metal implants, claustrophobia)
  • Ongoing psychotherapy or initiation of a new antidepressant medication within the past 4 weeks
  • Insufficient German language proficiency to participate in therapy and complete study assessments
  • Cognitive impairment or other conditions interfering with informed consent or study participation

研究组 & 干预措施

Expectation-Focused Psychotherapeutic Intervention (EFPI)

Experimental

Participants receive 10 group therapy sessions (2 sessions per week over 5 weeks) of EFPI, a mechanism-based psychotherapy targeting maladaptive expectations.

The intervention combines psychoeducation, structured behavioral experiments, and cognitive restructuring to systematically challenge negative expectations.

A central focus is reducing cognitive immunization-the tendency to dismiss or reframe positive disconfirming evidence-to foster more flexible and adaptive belief updating.

Sessions are conducted in small groups (5-10 participants) to facilitate peer modeling, social reinforcement, and shared learning.

The first session includes baseline clinical assessments, and the final session includes immediate post-treatment assessments.

All participants are additionally followed up at 3 and 6 months after the intervention to evaluate the persistence of treatment effects.

干预措施: Expectation-Focused Psychotherapeutic Intervention (Behavioral)

Reward Enhancement and Activation Therapy (REACT)

Experimental

Participants receive 10 group therapy sessions (2 sessions per week over 5 weeks) of REACT, a mechanism-based psychotherapy designed to enhance reward sensitivity.

Core intervention components include attentional retraining toward rewarding stimuli, savoring exercises to prolong positive affect, and structured reinforcement plans to strengthen motivation and engagement in rewarding activities.

Group discussions normalize difficulties in experiencing pleasure and provide strategies for sustaining rewarding behavior long-term.

Sessions are conducted in small groups (5-10 participants). The first session includes baseline assessments, and the final session includes immediate post-treatment assessments.

Long-term outcomes are assessed through follow-up evaluations at 3- and 6-months post-intervention.

干预措施: Reward Enhancement and Activation Therapy (Behavioral)

Waiting-List Control

No Intervention

Participants assigned to the waiting-list control condition do not receive active treatment during the initial 3-month period.

They complete baseline assessments at study entry and a follow-up assessment after 3 months, corresponding to the time frame of the active intervention arms.

After the 3-month assessment, participants are ethically permitted to pursue standard care outside the study.

For comparability and long-term analyses, waiting-list participants continue to complete follow-up assessments at 6 months, including questions about any additional treatments received after the waiting-list phase.

结局指标

主要结局

Change in Depressive Symptoms (Beck Depression Inventory-II)

时间窗: Baseline, post-treatment (5 weeks), 3-month and 6-month follow-ups

Change in depressive symptom severity assessed with the Beck Depression Inventory-II (BDI-II), a 21-item self-report questionnaire measuring cognitive, affective, and somatic symptoms of depression. Total scores range from 0 to 63, with higher scores indicating more severe depressive symptoms. The primary endpoint is the change from baseline to post-treatment (5 weeks). Symptom stability and maintenance will be examined at follow-up assessments.

次要结局

  • Change in Depressive Symptoms (Hamilton Depression Rating Scale, 21-item)(Baseline and post-treatment (5 weeks))
  • Depressive Expectations (Depressive Expectations Scale)(Baseline, post-treatment (5 weeks), 3-month and 6-month follow-ups)
  • Hopelessness (Beck Hopelessness Scale)(Baseline, post-treatment (5 weeks), 3-month and 6-month follow-ups)
  • Socially Negative Expectations (Social Anxiety-Negative Beliefs Scale, SANB-5)(Baseline, post-treatment (5 weeks), 3-month and 6-month follow-ups)
  • Behavioral Activation and Reward Responsiveness (Behavioral Activation System Scale)(Baseline, post-treatment (5 weeks), 3-month and 6-month follow-ups)
  • Resilience (Resilience Scale, RS-25)(Baseline, post-treatment (5 weeks), 3-month and 6-month follow-ups)
  • General Self-Efficacy (Allgemeine Selbstwirksamkeit Kurzskala, ASKU)(Baseline, post-treatment (5 weeks), 3-month and 6-month follow-ups)
  • Treatment Expectations and Experiences (Generic Expectation Evaluation Questionnaire)(Baseline, post-treatment (5 weeks), 3-month and 6-month follow-ups)
  • Suicidal Ideation and Behavior (Suicide Behaviors Questionnaire-Revised)(Baseline, post-treatment (5 weeks), 3-month and 6-month follow-ups)

研究者

发起方
Philipps University Marburg
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验